ClinicalTrials.gg
RecruitingNCT07111962Updated Feb 10, 2026

Effectiveness of NOA OATMAD

An observational study in Obstructive Sleep Apnea, sponsored by University of Alberta. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by University of Alberta · Observational

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Sleep Apnea, Obstructive by University of Alberta — 5 open to participants now, 5 under way, none of them phase 3. Sleep Apnea, Obstructive · University of Alberta.

Started
2025
the only one that year
Observational
4 of 10
1 open now
Registered
10th of 10
by date

Among the 10 studies in Sleep Apnea, Obstructive by University of Alberta, this one is the only one that started in 2025, is one of 4 observational ones, and was the 10th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

5 of the 10 studies in Sleep Apnea, Obstructive by University of Alberta are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Sleep Apnea, Obstructive by University of Alberta, or all of them as a file.
02

Study summary

This study is looking at how well the OrthoApnea NOA appliance, a special custom-made mouthpiece, helps treat people with obstructive sleep apnea (OSA). OSA is a common sleep problem where a person's breathing starts and stops many times during the night. Some people find it hard to use the usual treatment, called a continuous positive airway pressure (CPAP) machine, so this mouthpiece might be an easier and more comfortable option. The study is also checking if a small tool called the Morning Aligner, worn briefly in the morning, can help move the jaw back to its normal position. This might help people feel better and reduce side effects.

The study will last for three years. During this time, researchers will watch how people do while using the OrthoApnea NOA and compare their results to those of other people who used different types of plastic mouthpieces. The main goal is to see if the NOA can cut the number of times a person stops breathing during sleep by at least half. They hope to reduce it to fewer than 5 times an hour, which is close to normal. They will also check other things like how much oxygen people get while sleeping, their weight, how sleepy they feel during the day, how comfortable the mouthpiece is, how long it lasts, and how often people keep using it.

Instead of picking who gets which mouthpiece at random, this study uses a different method. It compares new patients using the NOA to past patients who used other mouthpieces. This is more like what happens in real life at clinics. By studying both new and past data, the researchers hope to better understand how the NOA works over time and how it compares to other options. This information will help dentists, sleep doctors, and patients choose the best way to treat sleep apnea using mouthpieces.

Read the detailed description

Research Proposal: Evaluating the Effectiveness of the OrthoApnea NOA Dental Appliance in Treating Obstructive Sleep Apnea (OSA)

  1. Purpose of the Study This study will evaluate how effective the OrthoApnea NOA dental appliance is at treating patients with mild, moderate, and severe obstructive sleep apnea (OSA). It will also assess the Morning Aligner as a supporting tool to maintain jaw alignment and comfort.

    In addition to following patients prospectively over three years, this study will also analyze and compare pre-existing clinical data from other patients who have used different nylon-based mandibular advancement devices. This approach will allow us to assess relative performance in terms of treatment outcomes, comfort, and long-term adherence.

  2. Hypothesis The OrthoApnea NOA, used with the Morning Aligner, will reduce the Apnea-Hypopnea Index (AHI) by at least 50%, with a goal of bringing AHI to fewer than 5 events per hour in many patients.

    Compared to other nylon-based dental appliances, the NOA will show:

    Better long-term efficacy

    Longer retention time (device durability)

    Higher adherence to treatment

    Improved patient comfort and satisfaction

  3. Justification Dental sleep appliances are a valuable alternative for patients who cannot tolerate continuous positive airway pressure (CPAP) therapy. The OrthoApnea NOA is a custom-made, modern appliance designed for maximum comfort, adjustability, and effectiveness. Including the Morning Aligner in the treatment may enhance comfort and prevent bite changes.

    There is currently limited long-term real-world data comparing this device with other nylon-based appliances. This study aims to fill that gap by evaluating both new patients and historical patient data, providing robust evidence to support treatment decisions.

  4. Objectives Primary Objective To evaluate whether the OrthoApnea NOA reduces AHI by ≥50%, with a goal of achieving \<5 events per hour.

    Secondary Objectives

    Measure improvements in:

    AHI (Apnea-Hypopnea Index)

    CT90 (percentage of time with oxygen saturation below 90%)

    BMI (body mass index)

    Epworth Sleepiness Scale (ESS) scores

    Device retention/durability

    Jaw alignment and dental comfort

    Patient adherence and satisfaction

  5. Study Design and Methods Design Quasi-experimental, comparative longitudinal study

    Two groups:

    Prospective cohort using the OrthoApnea NOA + Morning Aligner

    Retrospective cohort of patients treated with other nylon-based oral appliances (existing clinic data)

    Sample

    Total Sample Size: 250

    Intervention Sample Size: 100 patients in the prospective NOA group

    Historical Comparison Group: 100-150 matched patients from prior records

    Sample Size and Power Calculation

    Calculated using the Harvard Hedwig sample size calculator sing a 2 sided alpha of 0.05, power of 0.9 with a standard deviation of 10 and a difference in means of 5 and a dropout rate of approximately 20% for the prospective group

  6. Data Collection and Follow-up

    Prospective Group (OrthoApnea NOA + Morning Aligner):

    Sleep studies at baseline, 6, 12, 18, 24, and 36 months

    CT90, BMI, ESS, and dental/jaw evaluations

    Patient questionnaires on comfort, satisfaction, and adherence

    Device assessments for wear and retention

    Retrospective Group (Other nylon appliances):

    Extract AHI, CT90, BMI, ESS, and device durability from patient records

    Match based on age, gender, OSA severity, and BMI

  7. Data Analysis Plan Primary Analysis

Compare changes in AHI from baseline to follow-up between the NOA group and retrospective nylon appliance group using:

Independent t-tests or ANCOVA for continuous variables (adjusting for baseline values)

Chi-square tests for categorical outcomes (e.g., proportion of patients achieving AHI \< 5)

Secondary Analyses Longitudinal trends in AHI, CT90, ESS, and BMI using mixed-effects models

Analysis of device durability and patient adherence using survival analysis or time-to-event methods

Evaluate correlations between adherence, comfort, and clinical improvement

Subgroup analysis by OSA severity (mild, moderate, severe)

Data Matching and Control

Retrospective data will be matched to prospective participants based on:

Age Sex Baseline AHI category BMI Propensity score matching may be used for more accurate comparisons

This study combines real-world clinical data with a prospective follow-up to evaluate the long-term effectiveness of the OrthoApnea NOA appliance and its companion Morning Aligner. It will provide strong, comparative evidence of its performance against other nylon-based devices in terms of sleep improvement, patient comfort, and adherence-information that is critically needed for guiding future treatment recommendations in dental sleep medicine.

03

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • obstructive sleep apnea
  • oral appliance therapy
  • mandibular advancement device
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

adults with OSA

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Dxed OSA being treated with NOA appliance

Exclusion criteria

Exclusion Criteria:

  • no OSA Dx
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. AHI

    Disease Index

    Time frame: 3 years

Secondary outcomes

  1. Side Effects

    Side Effects (changes to bite/occlusion, TMJ symptoms/myalgia)

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2030, 63 months after the start.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 63 months is above that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2025
First posted
Aug 8, 2025
StartActual
Sep 30, 2025
Primary completionEst.
Dec 31, 2030
CompletionEst.
Dec 31, 2030
Last update
Feb 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07111962
Collaborators
Orthoapnea
Responsible party
Sponsor
First posted
Aug 8, 2025
Start date
Sep 30, 2025
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Feb 10, 2026

Study contacts

Primary Investigator
Contact
airwayresearchdsm@gmail.com
(780) 492-7696

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion